Upon RAS-driven membrane recruitment, RAF kinases ARAF, BRAF, and CRAF are activated through homo- or heterodimerization to initiate MAP kinase signaling. Although RAF heterodimers drive physiologic and oncogenic signaling, they remain little studied structurally and biochemically. Here, we report the preparation, biochemical characterization, and cryo-EM structures of 14-3-3-bound BRAF/CRAF heterodimer complexes. The heterodimer exhibits kinetic parameters and RAF inhibitor sensitivities intermediate between, or closely matching, BRAF and CRAF homodimers. Cryo-EM structures reveal an organization identical to RAF homodimers, with an asymmetric interaction unique to the MEK1-bound structure in which the BRAF acidic NtA motif engages the CRAF RKTR motif. Mutagenesis reveals that replacing the acidic NtA sequence with basic RARA yields active dimers, showing that negative charge is dispensable for activity. Collectively, our findings suggest the NtA charge state influences RAF activity through effects on local backbone dynamics and inactive-state stability, rather than via stereospecific recognition across the dimer interface.
No takes yet. Share an insight, caveat, or question.
Ha et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: